Caroline J Loew

CAROLINE J LOEW is the head of R&D strategy and planning at Bristol-Myers Squibb, joining the company in December 2015. She leads a group responsible for providing the critical strategic and operational support for R&D’s continued success. She is a key advisor to the chief scientific officer and a member of R&D’s executive leadership team.  Previously, Loew led the Late Lifecycle Management Center of Excellence at Merck. Loew joined Merck in 2007 as VP, health technology assessment strategy development. Prior to working with Merck, Loew was the senior vice president for scientific and regulatory affairs at the Pharmaceutical Research and Manufacturers of America (PhRMA). She has extensive experience working with regulatory authorities in the U.S., European Union, Japan, Asia-Pacific and Latin America on key regulatory and drug development issues for the pharmaceutical industry, including as PhRMA’s representative to the International Conference on Harmonization (ICH) steering committee. Loew’s work at PhRMA built on her earlier experience in the pharmaceutical industry in drug development at both AstraZeneca and Abbott. An organic chemist by training, Loew did her undergraduate and postgraduate studies in chemistry at Imperial College, London, U.K. (including one year of research at the Ecole Superieur de Physique et Chimie Industrielles, Paris, France), followed by postdoctoral research at U.C. Irvine, USA. @bmsnews